Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumab
Christiane Meyer(University of Lausanne), Daniel E. Speiser(University of Lausanne)
Cited by 560
Related Papers
Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients
|Journal of Clinical Investigation|2011|820
Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients
|Proceedings of the National Academy of Sciences|2015|581
CD4+ T cells in cancer
|Nature Cancer|2023|450
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma
|Cancer Cell|2020|379
In Vivo Expression of Natural Killer Cell Inhibitory Receptors by Human Melanoma–Specific Cytolytic T Lymphocytes
|The Journal of Experimental Medicine|1999|196